Chemoprevention of second primary tumours in head and neck cancer in Europe: EUROSCAN
- PMID: 7719218
- DOI: 10.1016/0964-1955(94)90012-4
Chemoprevention of second primary tumours in head and neck cancer in Europe: EUROSCAN
Similar articles
-
EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. For the EUropean Organization for Research and Treatment of Cancer Head and Neck and Lung Cancer Cooperative Groups.J Natl Cancer Inst. 2000 Jun 21;92(12):977-86. doi: 10.1093/jnci/92.12.977. J Natl Cancer Inst. 2000. PMID: 10861309 Clinical Trial.
-
Chemoprevention in the management of oral cancer: EUROSCAN and other studies.Eur J Cancer B Oral Oncol. 1992 Oct;28B(2):153-7. doi: 10.1016/0964-1955(92)90045-3. Eur J Cancer B Oral Oncol. 1992. PMID: 1306732 Review. No abstract available.
-
The EUROSCAN Study. EUROSCAN Steering Committee.Br J Cancer. 1991 Dec;64(6):985-9. doi: 10.1038/bjc.1991.451. Br J Cancer. 1991. PMID: 1764390 Free PMC article. Clinical Trial. No abstract available.
-
Chemoprevention of cancer.Eur Respir J. 1993 Mar;6(3):322-4. Eur Respir J. 1993. PMID: 8472818 Clinical Trial. No abstract available.
-
Chemoprevention of head and neck cancer.Semin Oncol. 1994 Jun;21(3):366-75. Semin Oncol. 1994. PMID: 8209268 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical